CSL Ltd Shares Update

Submitted by Craig Strzelecki on 28 March, 2007 - 19:13

CSL Ltd shares update. Pediatricians in the USA balking at cost of vaccines: Soaring costs and the rising number of new vaccines are making it difficult for some doctors to buy shots to give to patients. Germany ahead of Schedule: Germany, which is Europe's biggest drugs market, has added Gardasil to the national schedule for standard vaccinations, four months ahead of schedule. Germany is recommending universal vaccination of girls aged 12 to 17 years. Next IP Update: CSL announced this morning the results of a test to reduce coronary plaque.

CSL Limited is listed on the Australian Stock Exchange (ASX) under stock code CSL. You can view their investor website here. CSL was listed on the ASX on 8 June, 1994. Elizabeth Alexander is the chairman for CSL and Brian A McNamee the CEO. This company is a global, specialty biopharmaceutical company that develops, manufactures and markets products to treat and prevent serious human medical conditions. They are involved in the development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions. Find out the meaning of the recommendations in this primer. Browse for other stockbroker recommendations. You can use Instalment Warrants to trade CSL. Check your charts and good luck with your share trading!